Camlin Fine Sciences Limited (CAMLINFINE.BO)
- Previous Close
243.70 - Open
241.05 - Bid 232.10 x --
- Ask 233.55 x --
- Day's Range
225.25 - 243.25 - 52 Week Range
80.00 - 251.90 - Volume
209,264 - Avg. Volume
118,651 - Market Cap (intraday)
43.663B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
81.24 - EPS (TTM)
2.86 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 28, 2016
- 1y Target Est
255.00
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, and rosemary extract that are used to enhance the shelf life under the Xtendra and NaSure brands. It also provides aroma ingredients, including vanillin and ethyl vanillin; health and wellness products; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food, animal nutrition, rendering, health and wellbeing, chemicals, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
www.camlinfs.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CAMLINFINE.BO
Mehr anzeigenPerformance Overview: CAMLINFINE.BO
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Vergleichen mit: CAMLINFINE.BO
Auswählen, um ähnliche Unternehmen anhand wichtiger Performance-Metriken zu analysieren; bis zu 4 Aktien auswählen.
Statistics: CAMLINFINE.BO
Mehr anzeigenValuation Measures
Market Cap
43.66B
Enterprise Value
48.53B
Trailing P/E
81.24
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.41
Price/Book (mrq)
4.84
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
19.67
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.34%
Return on Assets (ttm)
4.54%
Return on Equity (ttm)
5.71%
Revenue (ttm)
16.67B
Net Income Avi to Common (ttm)
684.78M
Diluted EPS (ttm)
2.86
Balance Sheet and Cash Flow
Total Cash (mrq)
1.54B
Total Debt/Equity (mrq)
77.88%
Levered Free Cash Flow (ttm)
621.26M